Samaa Al Tabbah: Landmark Iraqi Consensus on ITP Published
Samaa Al Tabbah,ย Senior Lead Consultant at MEDHEALTH PRO, shared a post on LinkedIn:
“A Landmark for Hematology in Iraq: Consensus Recommendations for ITP Published
It is a privilege to share the publication of a significant milestone for hematology in Iraq: the “๐๐ซ๐๐ช๐ข ๐๐จ๐ง๐ฌ๐๐ง๐ฌ๐ฎ๐ฌ ๐ซ๐๐๐จ๐ฆ๐ฆ๐๐ง๐๐๐ญ๐ข๐จ๐ง๐ฌ ๐๐จ๐ซ ๐ญ๐ก๐ ๐๐ข๐๐ ๐ง๐จ๐ฌ๐ข๐ฌ ๐๐ง๐ ๐ฆ๐๐ง๐๐ ๐๐ฆ๐๐ง๐ญ ๐จ๐ ๐ข๐ฆ๐ฆ๐ฎ๐ง๐ ๐ญ๐ก๐ซ๐จ๐ฆ๐๐จ๐๐ฒ๐ญ๐จ๐ฉ๐๐ง๐ข๐.” This crucial document, now published in the prestigious journal ๐ฏ๐๐๐๐๐๐๐๐๐, represents a unified effort to standardize and improve patient care across the country.
This consensus is the result of nearly two years of dedicated collaboration among Iraq’s leading experts. ๐ ๐๐ฆ ๐ข๐ฆ๐ฆ๐๐ง๐ฌ๐๐ฅ๐ฒ ๐ฉ๐ซ๐จ๐ฎ๐ ๐ญ๐จ ๐ก๐๐ฏ๐ ๐ฅ๐๐ ๐ญ๐ก๐ ๐ฆ๐๐๐ข๐๐๐ฅ ๐ฐ๐ซ๐ข๐ญ๐ข๐ง๐ ๐๐จ๐ซ ๐ญ๐ก๐ข๐ฌ ๐ฉ๐ซ๐จ๐ฃ๐๐๐ญ, ๐ฐ๐จ๐ซ๐ค๐ข๐ง๐ ๐ญ๐จ ๐ฌ๐ฒ๐ง๐ญ๐ก๐๐ฌ๐ข๐ณ๐ ๐ญ๐ก๐ ๐๐จ๐ฅ๐ฅ๐๐๐ญ๐ข๐ฏ๐ ๐๐ฑ๐ฉ๐๐ซ๐ญ๐ข๐ฌ๐ ๐ข๐ง๐ญ๐จ ๐ ๐๐ฅ๐๐๐ซ ๐๐ง๐ ๐ข๐ฆ๐ฉ๐๐๐ญ๐๐ฎ๐ฅ ๐ฆ๐๐ง๐ฎ๐ฌ๐๐ซ๐ข๐ฉ๐ญ.
My deepest gratitude and a heartfelt congratulations go to the entire author panel for their invaluable insights and unwavering commitment: ๐๐ก๐ฆ๐๐ ๐๐ฃ๐๐ฅ๐ข, ๐๐๐ฌ๐ฌ๐๐ฆ ๐ ๐ซ๐๐ง๐๐ข๐ฌ ๐๐๐ญ๐ญ๐ข, ๐๐๐ฅ๐๐๐ ๐๐ก๐๐ง๐ข๐ฆ๐, ๐๐ซ๐๐ฐ ๐๐ซ๐จ๐ฏ๐๐ง, ๐๐๐ซ๐๐๐ง ๐๐๐ฐ๐๐๐๐ช ๐๐๐๐๐ฌ, ๐๐ฅ๐๐๐๐ข๐ง ๐๐๐ก๐ก๐๐ฆ ๐๐๐ฃ๐ข, ๐๐จ๐ก๐๐ฆ๐ฆ๐๐ ๐๐๐ฅ๐๐๐ฆ ๐๐๐๐๐ฌ, ๐๐ฅ๐๐ ๐ ๐๐๐ก๐ข๐ฅ ๐๐ฅ๐ฐ๐๐ง, ๐๐๐ฌ๐๐๐ฆ ๐ ๐๐ฅ ๐๐๐ฆ๐๐๐ฆ๐ข, ๐๐๐ซ๐๐ช ๐๐๐๐ฎ๐ฅ๐ฅ๐๐ก ๐๐๐ฅ๐๐ก, ๐๐๐ณ๐ข๐ง ๐๐ก๐ฎ๐๐๐๐ซ, ๐๐ก๐ฆ๐๐ ๐๐๐๐๐ก ๐๐จ๐จ๐ซ๐ข, ๐๐๐ ๐ก๐๐ ๐๐๐ฃ๐ข๐ ๐๐ฅ-๐๐๐๐๐, ๐๐ฆ๐๐ซ ๐๐ก๐๐ซ๐๐๐ ๐๐จ๐ก๐๐ฆ๐ฆ๐๐, ๐๐จ๐ก๐๐ฆ๐ฆ๐๐ ๐๐ก๐ฆ๐๐ ๐๐ฅ-๐๐ง๐ฌ๐ฌ๐๐ซ๐ข, ๐๐ง๐ ๐๐ฎ๐ญ๐๐ข๐๐ ๐. ๐๐๐ฐ๐จ๐จ๐.
Furthermore, I would like to extend a special thanks to Dr. Ahmed Mjali for his exceptional collaboration and guidance throughout the entire process.
This achievement is a testament to the power of teamwork in advancing medical science. This consensus will undoubtedly serve as an essential resource for clinicians and a beacon of hope for patients. Congratulations to all involved on seeing this vital work come to light ”
Title:ย Iraqi consensus recommendations for the diagnosis and management of immune thrombocytopenia
Authors:ย Ahmed Mjali ,Bassam Francis Matti ,Waleed Ghanima ,Drew Provan ,Nareen Tawfeeq Abbas ,Alaadin Sahham Naji, Mohammed Saleem Abbas ,Alaa Fadhil Alwan ,Waseem F Al Tameemi ,Tareq Abdullah Saleh ,Mazin A. Shubber ,Ahmed Sabah Noori ,Raghad Majid Al-Saeed ,Amer Shareef Mohammed ,Mohammed Ahmed Al-Anssari and Qutaiba M. Dawood

Read full article here.
Stay updated with Hemostasis Today.
-
Nov 29, 2025, 18:55Ahmad Thuaimer: Success Story – Advanced Interventional Care for DVT
-
Nov 29, 2025, 17:37Almahdi Ali Explores Ipsilateral Paradoxical Thromboembolism at 22nd European Angiology Days 2025
-
Nov 29, 2025, 17:23Jack Shuang Hou Shares Major Neurology Updates This Week
-
Nov 29, 2025, 16:52Federica Fogacci on Further Strengthening Collaboration Within the Lp(a)CCELERATE Study
-
Nov 29, 2025, 16:42Dr Abdul Mannan on the Echinocyte: Mastering the Diagnostic Duality of Artifact vs. Pathology
-
Nov 29, 2025, 16:42Vikas Dua: Heme Next 1.0 A Conference with a Difference
-
Nov 29, 2025, 16:41Hind Ali: Sources Of Error in Cell Counts
-
Nov 29, 2025, 16:40Maxime Dely: Even on a Break, You Can Give
-
Nov 29, 2025, 16:39Shrinidhi Nathany: HemeNext Brings Science, Technology, and Leadership Together
